Open Access
CC BY 4.0 · Brazilian Journal of Oncology 2025; 21
DOI: 10.1055/s-0045-1807950
PREVENTION, SCREENING, AND DIAGNOSIS
1895
POSTER PRESENTATION

Cost-effectiveness of lung cancer screening in a high-risk population in Brazil

Authors

  • Clarissa Baldotto

  • Mauricio Cristiano Rocha-Junior

  • Gustavo Faibischew Prado

  • Wolfgang W. Schmidt Aguiar

  • Francisco Neto

  • Vladmir Cordeiro de Lima

  • Samira Mascarenhas

  • Thiago Fagundes

  • Tamiê de Camargo Martins

  • Cintia Kurokawa La Scala de Oliveira

  • Nelson Francisco Correa-Netto

Further Information
 
  All articles of this category

    Keywords

    lung cancer - high risk - screening - cost effectiveness

    Objectives: Establish whether CP screening for computed tomography every 2 years is cost-effective in a high-risk population in the perspective of the Brazilian public health scenario.

    Methods: For the quantification of the tracked population: smokers and ex-smokers 20 packs/year, aged between 50 and 80 years, it has been used information provided by the IBGE 2020 Demographic Census (Instituto Brasileiro de Geografia e Estatística) and Vigitel 2023 (Sistema de Vigilância de Fatores de Risco e Proteção para Doenças Crônicas por Inquérito Telefônico). Additionally, a non-tracked comparative population was outlined from the FOSP database (Fundação Oncocentro de São Paulo). To define the patient's journey and direct and indirect costs, DATASUS (Departamento de Informática so SUS) bases and information from an expert's panel to validate assumptions were used. For economic evaluations the models of Markov were used, considering the costs of treatment and outcomes.

    Results: Based on cost- effectiveness analysis (CEA) it was possible to demonstrate that the adoption of a lung cancer (LC) screening strategy with low-dose computed tomography (LDCT) in a previously defined high-risk populations (age between 50 and 80 years and current smokers and former smokers with a smooth load of 20 packs-year) was cost-effective with positive QALY results.

    Conclusions: This study confirmed the premise that the implementation of LC tracking protocol in high-risk populations is cost-effective as early diagnosis and treatment provide medical and social benefits, balancing health costs, higher standards of Overall Survival (OS) and Disease Free Progression (DFP) as well as the possibility of social and family reintegration of the patients, maintaining their productivity.

    Corresponding author: Tamie de Camargo Martins (e-mail: tamie.de_camargo_martins@roche.com).


     

    No conflict of interest has been declared by the author(s).

    Publication History

    Article published online:
    06 May 2025

    © 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution 4.0 International License, permitting copying and reproduction so long as the original work is given appropriate credit (https://creativecommons.org/licenses/by/4.0/)

    Thieme Revinter Publicações Ltda.
    Rua Rego Freitas, 175, loja 1, República, São Paulo, SP, CEP 01220-010, Brazil

    Bibliographical Record
    Clarissa Baldotto, Mauricio Cristiano Rocha-Junior, Gustavo Faibischew Prado, Wolfgang W. Schmidt Aguiar, Francisco Neto, Vladmir Cordeiro de Lima, Samira Mascarenhas, Thiago Fagundes, Tamiê de Camargo Martins, Cintia Kurokawa La Scala de Oliveira, Nelson Francisco Correa-Netto. Cost-effectiveness of lung cancer screening in a high-risk population in Brazil. Brazilian Journal of Oncology 2025; 21.
    DOI: 10.1055/s-0045-1807950
      All articles of this category